A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA
about
Condensation of oligonucleotides assembled into nicked and gapped duplexes: potential structures for oligonucleotide deliveryAchieving efficient delivery of morpholino oligos in cultured cellsPolymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms.Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzymeTargeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.The spherulites(TM): a promising carrier for oligonucleotide delivery.New phosphoramidite reagents for the synthesis of oligonucleotides containing a cysteine residue useful in peptide conjugation.Rapid routes of synthesis of oligonucleotide conjugates from non-protected oligonucleotides and ligands possessing different nucleophilic or electrophilic functional groups.Inhibition of the human chemokine receptor CXCR4 by antisense phosphorothioate oligodeoxyribonucleotides.Functional analysis of newly discovered growth control genes: experimental approaches.Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotidesUltrasmall gold nanoparticles as carriers for nucleus-based gene therapy due to size-dependent nuclear entryA novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.cAMP acts as a second messenger in pollen tube growth and reorientation.Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotideAddition of ascorbic acid to the extracellular environment activates lipoplexes of a ferrocenyl lipid and promotes cell transfectionPeptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells.Oligonucleotides and polyribonucleotides: a review of antiviral activity.The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation.Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.Inhibition of human telomerase by 2'-O-methyl-RNAA cytosine analog that confers enhanced potency to antisense oligonucleotides.Chemical activation of lipoplexes formed from DNA and a redox-active, ferrocene-containing cationic lipid.Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide.A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.Antisense inhibition of Flk-1 by oligonucleotides composed of 2'-deoxy-2'-fluoro-beta-D-arabino- and 2'-deoxy-nucleosides.Antisense phosphorothioate oligonucleotides targeted to the human chemokine receptor CXCR4.Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency.Oligodeoxynucleotides containing C-7 propyne analogs of 7-deaza-2'-deoxyguanosine and 7-deaza-2'-deoxyadenosine.Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.Novel dextran-spermine conjugates as transfecting agents: comparing water-soluble and micellar polymers.Modifications in the head group and in the spacer of cholesterol-based cationic lipids promote transfection in melanoma B16-F10 cells and tumours.Targeting of iNOS with antisense DNA plasmid reduces cytokine-induced inhibition of osteoblastic activity.Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells.Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives.Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability.Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection.Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
P2860
Q24793712-FCDAA508-7933-44C0-9D1E-59DDD06ECCDDQ28209637-06CF01F0-462E-4DB1-AD56-D14A1CB009BFQ30537017-484BF38B-CD3B-46B7-BD1C-D474731A953DQ30673942-AE39B80C-9BAC-4E42-8A96-CAF9CBE49FA4Q30708934-40CF8DEB-4CE7-4618-B203-ECE6E2546B8CQ30897989-C816F9BC-7BFA-4E63-93EF-9F8311A700AFQ30980242-7BFF2D56-A4F6-4E7D-B4AE-AB7E91CC2C13Q30980249-5E61E2EC-11E2-45B8-9301-4236D9884AEFQ31864643-BF70B38F-972E-4B1E-8DB9-942BF4CBB108Q33716358-9C8CDCE3-FF01-4DBB-BE35-AC15C175E9DCQ33732824-CB2B70DE-6292-46DF-8BF8-19455202F2FBQ33754501-A230FAD4-A534-4160-8352-28E4608CFCEFQ33824831-B2721755-D0E2-4CE9-AF1A-94442A1399A7Q33853645-5308B06F-9D34-4013-949C-38897FD4B73EQ33943319-33380DB5-F3A3-49E0-B1DF-340FBE40E556Q33978043-33B8E0D3-4860-4441-A67D-F243913CB24DQ35675391-9BCAAAB8-BDEF-40D7-BEDA-C94ADEC9F72BQ35860526-A21C18A7-2BB1-493A-8FCE-B46C5664E09AQ36124734-2D67D842-B6D1-45C1-A7F1-6463E9958C0FQ36248087-842D8A6F-C205-4DF5-9DB9-F2DA2B0C1DA8Q36310068-430D6FE0-C5B4-44C0-8A98-629466ECA435Q36312946-169FAEDF-7720-48A8-9EF2-0400C247AE92Q36441952-6E520907-B98C-4A4C-A55C-8F8F2DB6763EQ37105021-39974C50-8B42-4FA8-9876-7CFB4561A009Q38329058-0DB664A1-2B43-42E9-BA5A-C4089931DFDDQ38344289-7739A63E-3AFC-4360-A525-5781DA8BB2D8Q38360548-31169BD6-CCB6-4C83-9335-F1672EC1F351Q39153573-8A29DC07-F162-4906-A460-CDB7974865F7Q39717027-EC6C1E76-816D-4E64-A89D-1EFD06CE0D7EQ39717046-C225FB1A-E01A-42B4-AD53-0D0DE2B7D1D2Q39723515-89B917E0-974E-4C04-B1D0-C69912E3EAFFQ40487818-F043EF62-7F18-46E4-BCD1-72A051CC6595Q40544064-DB8BBBCD-A9D6-4EE5-861B-EAFA1760AA2CQ40661479-99F76151-104F-4A00-B6A4-66F12392230BQ40718952-685574FE-1B61-443E-9591-B98D6C8F620FQ40796723-A3FC3093-A306-4A41-9B9E-C2A2D82BD491Q40825417-058AC388-E781-4108-8EF2-90BB17AEC872Q40886874-5D84C59C-240F-4AB9-9AB7-54EED1284562Q40938167-DF262AB7-5583-45EA-961D-E9EC919D1FFFQ40939824-911B2120-ABA9-4E71-85FF-E796900FB6DD
P2860
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A serum-resistant cytofectin f ...... oxynucleotides and plasmid DNA
@en
A serum-resistant cytofectin f ...... xynucleotides and plasmid DNA.
@nl
type
label
A serum-resistant cytofectin f ...... oxynucleotides and plasmid DNA
@en
A serum-resistant cytofectin f ...... xynucleotides and plasmid DNA.
@nl
prefLabel
A serum-resistant cytofectin f ...... oxynucleotides and plasmid DNA
@en
A serum-resistant cytofectin f ...... xynucleotides and plasmid DNA.
@nl
P2093
P2860
P356
P1476
A serum-resistant cytofectin f ...... oxynucleotides and plasmid DNA
@en
P2093
DePrince RB
Flanagan WM
Hendren RW
Kothavale A
Matteucci MD
Mook RA Jr
P2860
P304
P356
10.1073/PNAS.93.8.3176
P407
P577
1996-04-01T00:00:00Z